Search research articles
Contact Us
Filters
Showing results (451-460 of 568) with videos related to
Page
of 57
Sort By:
Arthritis and Rheumatism
|
October 11, 2001
Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis
S Ballara, P C Taylor, P Reusch, et al.
British Journal of Rheumatology
|
June 1, 1997
Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy
F M Brennan, K A Browne, P A Green, et al.
Annals of the Rheumatic Diseases
|
December 1, 1999
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis
R N Maini, P C Taylor, E Paleolog, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 2, 2000
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
A M Malfait, R Gallily, P F Sumariwalla, et al.
Clinical and Experimental Immunology
|
December 1, 1991
Transforming growth factor-beta 1 in rheumatoid synovial membrane and cartilage/pannus junction
C Q Chu, M Field, E Abney, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology
|
February 24, 2001
Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy
R N Maini, P C Taylor, E Paleolog, et al.
Pediatrie
|
January 1, 1992
[Bourneville tuberous sclerosis manifested by prenatal finding of intracardiac tumors]
R Destuynder, A Menget, C Fromentin, et al.
Klinische Wochenschrift
|
October 1, 1986
Comparative investigation of the microcirculation in patients with hypertension and healthy adults
F Jung, S Spitzer, H Kiesewetter, et al.
Clinical and Experimental Rheumatology
|
December 10, 1999
Combination therapy with DMARDs and biological agents in collagen-induced arthritis
R O Williams, A M Malfait, D M Butler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 1999
The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action
A M Malfait, A S Malik, L Marinova-Mutafchieva, et al.
Page
of 57
Search research articles
Search
Showing results (451-460 of 568) with videos related to
Sort By:
Page
of 57
Arthritis and Rheumatism
|
October 11, 2001
Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis
S Ballara, P C Taylor, P Reusch, et al.
British Journal of Rheumatology
|
June 1, 1997
Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy
F M Brennan, K A Browne, P A Green, et al.
Annals of the Rheumatic Diseases
|
December 1, 1999
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis
R N Maini, P C Taylor, E Paleolog, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 2, 2000
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
A M Malfait, R Gallily, P F Sumariwalla, et al.
Clinical and Experimental Immunology
|
December 1, 1991
Transforming growth factor-beta 1 in rheumatoid synovial membrane and cartilage/pannus junction
C Q Chu, M Field, E Abney, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology
|
February 24, 2001
Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy
R N Maini, P C Taylor, E Paleolog, et al.
Pediatrie
|
January 1, 1992
[Bourneville tuberous sclerosis manifested by prenatal finding of intracardiac tumors]
R Destuynder, A Menget, C Fromentin, et al.
Klinische Wochenschrift
|
October 1, 1986
Comparative investigation of the microcirculation in patients with hypertension and healthy adults
F Jung, S Spitzer, H Kiesewetter, et al.
Clinical and Experimental Rheumatology
|
December 10, 1999
Combination therapy with DMARDs and biological agents in collagen-induced arthritis
R O Williams, A M Malfait, D M Butler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 1999
The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action
A M Malfait, A S Malik, L Marinova-Mutafchieva, et al.
Page
of 57